Avyantra Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $87.9K

  • Investors
  • 5

Avyantra General Information

Description

Operator of a health tech company intended to address critical healthcare challenges. The company offers an assessment platform that utilizes artificial intelligence and machine learning to assess and predict the risk of neonatal sepsis and an automated peritoneal dialysis device that allows home-based therapy for patients with kidney failure, enabling healthcare providers and individuals with treatments available to broader populations, particularly in resource-constrained environments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Flat Number 203, Block Number.2, DG 6, IJM Rain Malaysian Township
  • KPHB Colony, 14th Phase, Rangareddi
  • Hyderabad, Telangana 500085
  • India
Primary Industry
Therapeutic Devices
Other Industries
Decision/Risk Analysis
Corporate Office
  • Flat Number 203, Block Number.2, DG 6, IJM Rain Malaysian Township
  • KPHB Colony, 14th Phase, Rangareddi
  • Hyderabad, Telangana 500085
  • India

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avyantra Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 10-Jan-2025 $87.9K Completed Generating Revenue
6. Accelerator/Incubator 16-Mar-2021 Completed Generating Revenue
5. Accelerator/Incubator 20-Jun-2020 Completed Generating Revenue
4. Grant Completed Generating Revenue
3. Seed Round 30-Mar-2020 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Avyantra’s complete valuation and funding history, request access »

Avyantra Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Avyantra’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Avyantra Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
SAGE Venture Fund Corporation Minority
ASPIRE-BioNEST Accelerator/Incubator
UNICEF Venture Fund Venture Capital Minority
Centre for Cellular And Molecular Platforms Accelerator/Incubator
IIIT-H Foundation Accelerator/Incubator
To view Avyantra’s complete investors history, request access »

Avyantra FAQs

  • When was Avyantra founded?

    Avyantra was founded in 2017.

  • Where is Avyantra headquartered?

    Avyantra is headquartered in Hyderabad, India.

  • What industry is Avyantra in?

    Avyantra’s primary industry is Therapeutic Devices.

  • Is Avyantra a private or public company?

    Avyantra is a Private company.

  • What is the current valuation of Avyantra?

    The current valuation of Avyantra is .

  • What is Avyantra’s current revenue?

    The current revenue for Avyantra is .

  • How much funding has Avyantra raised over time?

    Avyantra has raised $128K.

  • Who are Avyantra’s investors?

    SAGE Venture Fund, ASPIRE-BioNEST, UNICEF Venture Fund, Centre for Cellular And Molecular Platforms, and IIIT-H Foundation have invested in Avyantra.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process